Identification of an intestine-specific promoter and inducible expression of bacterial α-galactosidase in mammalian cells by a lac operon system by Zhai Ya-Feng et al.
JOURNAL OF ANIMAL SCIENCE
AND BIOTECHNOLOGY
Zhai et al. Journal of Animal Science and Biotechnology 2012, 3:32
http://www.jasbsci.com/content/3/1/32RESEARCH Open AccessIdentification of an intestine-specific
promoter and inducible expression of bacterial
α-galactosidase in mammalian cells by a lac
operon system
Yafeng Zhai†, Gang Shu†, Xiaotong Zhu, Zhiqi Zhang, Xiajing Lin, Songbo Wang, Lina Wang, Yongliang Zhang and
Qingyan Jiang*Abstract
Background: α-galactosidase has been widely used in animal husbandry to reduce anti-nutritional factors (such as
α-galactoside) in feed. Intestine-specific and substrate inducible expression of α-galactosidase would be highly
beneficial for transgenic animal production.
Methods: To achieve the intestine-specific and substrate inducible expression of α-galactosidase, we first identified
intestine-specific promoters by comparing the transcriptional activity and tissue specificity of four intestine-specific
promoters from human intestinal fatty acid binding protein, rat intestinal fatty acid binding protein, human
mucin-2 and human lysozyme. We made two chimeric constructs combining the promoter and enhancer of
human mucin-2, rat intestinal trefoil factor and human sucrase-isomaltase. Then a modified lac operon system
was constructed to investigate the induction of α-galactosidase expression and enzyme activity by isopropyl
β-D-1-thiogalactopyranoside (IPTG) and an α-galactosidase substrate, α-lactose.
We declared that the research carried out on human (Zhai Yafeng) was in compliance with the Helsinki Declaration,
and experimental research on animals also followed internationally recognized guidelines.
Results: The activity of the human mucin-2 promoter was about 2 to 3 times higher than that of other
intestine-specific promoters. In the lac operon system, the repressor significantly decreased (P < 0.05) luciferase
activity by approximately 6.5-fold and reduced the percentage of cells expressing green fluorescent protein (GFP)
by approximately 2-fold. In addition, the expression level of α-galactosidase mRNA was decreased by 6-fold and
α-galactosidase activity was reduced by 8-fold. In line with our expectations, IPTG and α-lactose supplementation
reversed (P < 0.05) the inhibition and produced a 5-fold increase of luciferase activity, an 11-fold enhancement in
the percentage of cells with GFP expression and an increase in α-galactosidase mRNA abundance (by about 5-fold)
and α-galactosidase activity (by about 7-fold).
Conclusions: We have successfully constructed a high specificity inducible lac operon system in an
intestine-derived cell line, which could be of great value for gene therapy applications and transgenic animal
production.
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α-galactosidase, an exo-glycosidase enzyme that hydro-
lyzes Gal glycosidic bonds, has been widely used in both
medical research and animal husbandry. For example,
the α-galactosidase gene has been investigated for
the gene therapy of Fabry disease, which is caused by
a defect in α-galactosidase activity [1]. In addition, α-
galactosidase has been used as a tool for changing blood
type B to O because of its ability to diminish the cell
membrane antigen [2]. In animal husbandry, anti-
nutritional factors (like α-galactoside in soybean meal)
can cause flatulence and even permeability diarrhea in
monogastric animals [3], while α-galactosidase supple-
mentation in diets can not only improve the utilization of
oligosaccharides and nutrient absorption in the intestinal
tract but can also improve growth performance [4-6].
Human α-galactosidase has been used in a transgenic
mouse model for Fabry disease [1,7]; however, the cyto-
megalovirus (CMV) promoter used in these studies
demonstrated poor and nonspecific expression of α-
galactosidase in almost all tissues. Therefore, abundant
expression during the embryonic stage might cause
embryos to be aborted or stillborn [8].
To achieve the specific expression of an exogenous
gene in the gastrointestinal tract, several promoters have
been used for cell-specific gene delivery, such as the
human intestinal fatty acid binding protein promoter
(HIFABP) [9], the rat intestinal fatty acid binding protein
promoter (RIFABP) [10], the human mucin-2 promoter
(HMUC2) [11], the human lysozyme promoter (HLY)
[12], the human sucrase-isomaltase enhancer (HSI) [13]
and the rat intestinal trefoil factor (RITF) [14]. Although
the activities of these intestine-specific promoters are
known, the regulatory element that is most appropriate
for directing α-galactosidase expression in intestinal cells
still required identification.
Some binary systems, such as the lac operon system
[15], the tetR-based system [16], the GAL4-based system
[17] and the Cre/loxP recombination system [18], have
been used to turn gene expression on and off transiently
or permanently. Bacterial lac operon-regulated gene ex-
pression in mammalian cells was first demonstrated by
Hu and Davidson [19]. Cronin et al. [15] also showed
that the lac operon system was functional in the mouse
and could provide tight and reversible gene expression.
The lac operon induction system might be the best
option for inducible α-galactosidase expression because
α-galactosidase hydrolysis of oligosaccharides or milk
can produce α-lactose, which binds to the lac repres-
sor and facilitates positive feedback of α-galactosidase
expression.
To achieve intestine-specific and substrate inducible
expression of α-galactosidase, we first compared the ac-
tivity and cell specificity of several regulatory elementsassociated with intestinal gene expression. Then an α-
galactosidase inducible expression vector was con-
structed based on the lac operon system. Luciferase
activity and α-galactosidase activity were also investi-
gated in response to isopropyl-β-D-thiogalactoside (IPTG)
and α-lactose to assess the construct’s ability to regulate
induction of target gene expression.Materials and methods
Plasmid construction
Three human intestine-specific promoters, HIFABP,
HMUC2 and HLY, and the HSI enhancer were amplified
by PCR using human genomic DNA template. The
RIFABP promoter was amplified by PCR using rat gen-
omic intestinal DNA template. The primers used are
shown in Table 1. The 59 bp RITF enhancer was chem-
ically synthesized. Six plasmids with four different pro-
moters and two different enhancers were constructed
using the pGL3-Basic plasmid backbone (Promega,
Shang Hai, China) (Figure 1A).
To construct the lac operon, the repressor gene (LacI)
was isolated from wild-type Escherichia coli, and a nu-
clear localization signal (NLS) was added during PCR
amplification [20,21]. LacI was then cloned in a pGL3-
control vector (Promega, China) by replacing the firefly
luciferase (luc) gene. The 116 bp operator (LacO)
(Figure 1B) was chemically synthesized and cloned in a
pGL3-Basic vector [22,23]. The reporter plasmid,
pBGFP, was constructed by replacing the luc gene with
green fluorescent protein (GFP) (from pshRNA-copGFP
Lentivector) as a negative control.
α-galactosidase (α-Gal) was obtained from a pPIC9-
Agil vector (a gift from Prof. Yao, Feed Research Insti-
tute Chinese Academy of Agricultural Sciences, China)
and then cloned into a pHMLacO vector by replacing
the luc gene. The plasmid , pHMLacO which luc gene
was replaced by α-Gal without the HMUC2 promoter
was used as a negative control.Cell culture and DNA transfection
Cells, including IPEC-1 (pig\jejunum), HeLa (human/
cervical), HepG2 (human\hepatic), NIH-3T3 (mouse/
embryonic fibroblast), 293T (human/kidney) and CHO
(hamster/ovary) were cultured in Dulbecco’s modified
Eagle’s medium, and SW480 (human/colon) cells were
cultured in Leibovitz’s L-15 medium (Gibco, China)
with 10% fetal bovine serum, penicillin G (100 U/mL),
streptomycin (100 μg/mL), and 2 mmol/L L-glutamine
at 37°C in 5% CO2/air. The IPEC-1 cell line was kindly
provided by Dr. Kong (Institute of Subtropical Agricul-
ture, the Chinese Academy of Sciences) and other cell
lines were obtained from the cell bank of Zhongshan
Medical College.
Table 1 Primers and regulatory element sequences used in this paper
Name1 GenBank Primer sequenc (5’-3’) Product (bp)
HMUC2 U67167 S:5’-CTAGCTAGCTCCTCCCAGCGTAACGTGAGC-3’ 466
A:5’-GAAGATCTCTAGTGGCAGCCCCATGGTG-3’
HIFABP NG_011444 S:5’-CCGACGCGTGTTAGATTTATCTTCCCTTGACC-3’ 1154
A:5’-CCGCTCGAGTACCTTCCAAGTGCTGTCAAAC-3’
RIFABP NW_047627 S:5’-CGACGCGTCATGCTGAATTCCTTAATTTGC-3’ 1232
A:5’-CCGCTCGAGCAGCTGTGTGTGCCTCTAGG-3’
HLY NM_000239 S:5’-CTAGCTAGCCTGTCCTCTTAGGCAGATACAGA-3’ 1186
A:5’- GAAGATCTAGAGCCTTCATGTTGACTGCTA-3’
HSI X85797 S: 5’- GGGGTACCCAATGAGTGCTATCTGTGGT-3’ 230
A: 5’-CGACGCGTAAGGAAAGCTGCTTAGGTA-3’
LacI V00294 S: 5'-CCCAAGCTTCCGGAAGAGAGTCAATTCAG-3' 1143
A:5'-GCTCTAGAAGTTTCGAAGGAGAAGAAGAATCCCTGCCCGCTTTCCAGTC'-3’
GFP AY268072.1 S: 5'-CCAAGCTTTTGTTTCGTTTTCTGTTCTGCG-3' 763
A: 5'-GCTCTAGAGCAGCGTATCCACATAGCGTAA-3'
α-Gal DQ344486 S: 5’-CATGCCATGGGCGGATGGTACTCTCTTTG-3’ 2153
A: 5’-GCTCTAGACTATTGCTTTTCCAACATCA-3’
RITF enhancer 5’-CGGGGTACCTGTTTTCCTCCCTAACCCTCTCCCCTCCCCCTCGGACTCCCACGCGTCGC-3’ 59
1HMUC2 = human mucin-2 promoter; HIFABP = human intestinal fatty acid binding protein promoter; RIFABP = rat intestinal fatty acid binding protein promoter;
HLY = human lysozyme promoter; HSI= human sucrase-isomaltase enhancer; LacI = lac operon repressor; GFP = green fluorescent protein; α-Gal = α-
galactosidase; RITF = rat intestinal trefoil factor.
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cort™ III (Wisegen, China) with approximately 1.5x105
cells/well in 24-well dishes and 2 μg of each DNA. Plas-
mids were purified with the E.Z.N.ATM EndoFee Plasmid
Kit (Omega, China). In all cases, 200 ng of a plasmid
containing the Renilla luciferase gene driven by the
TK promoter (pRL-TK vector, Promega, China) was
included in the assay to monitor transfection efficiency.
After 48 h, cells were measured for luciferase activity.
For induction experiments, both IPTG (Sigma, China)
and α-lactose (Sigma, China) were prepared as 100
mmol/L stock solutions in Dulbecco’s modified
phosphate-buffered saline without Ca2+ and Mg2+, pH
7.4 (PBS-).
For the transfection of a single plasmid, 4 μg of plas-
mid DNA was mixed with 10 μL of GenEscort™ III in
PBS(−), and made up to a total of 200 μL with Opti-
MEM (Gibco, China). For co-transfection, two plasmids
(3 μg each) were mixed with 14 μL of GenEscort™ III in
Opti-MEM to a total of 200 μL. These DNA/liposome
complexes were added to approximately 5x105 cells/well
in 6-well dishes and incubated for 48 h at 37°C. The
DNA/liposome complexes were added to SW480 cells
cultured in 25 cm2 cell culture bottles and incubated
for 96 h. For RNA extraction and α-galactosidase acti-
vity assays, medium was replaced by PBS prior to pro-
cessing, while for induction experiments, medium was
replaced with fresh media containing 2.5 mmol/L IPTGor 5 mmol/L α-lactose. The cells were induced for 12 h
before being observed for fluorescence and harvesting
for FACS.Fluorescence detection
Cells were observed using a Leica DMI 4000B fluor-
escence microscope (Leica) with DM505 filters
(BP460-490 and BA510IF) for GFP monitoring. Micro-
photographs were taken using a digital camera (FUJIX
HC-300/OL, FujiFilm) attached to the fluorescence
microscope.Fluorescence Activated Cell Sorting (FACS) analysis
Forty-eight hours after transfection, cells were washed
twice with PBS(−) and dissociated with trypsin/EDTA.
After centrifugation at 1,000 rpm for 5 min at 4°C, cells
were resuspended at 1x106 cells/mL in 1x Assay Buffer
(KeyGEN, China) and stored on ice for a maximum of
1 h before analysis. Then 5 μL 7-AAD (KeyGEN, China)
was added immediately prior to flow cytometry. Acquisi-
tion was performed on a FACSCalibur system (BD Bio-
science), and samples were analyzed using Cell Quest
Pro software (BD Bioscience). In each experiment,
10,000 counts were evaluated. Cells exhibiting 7-AAD
uptake were considered dead and excluded from the





Human LY promoter(1186bp) Luciferase P(A)
Rat IFABP promoter(1232bp)













CAP binding site GC box LacO1 TATA LacO2
B
Figure 1 Schematic structure of the intestine-specific promoters and operator. (A) Promoter/enhancer fusion constructs. Four intestine-
specific promoters were cloned into a pGL3-Basic vector to drive luciferase expression. In addition, the human mucin-2 promoter (HMUC2)
sequence was fused to the human sucrase–isomaltase (HSI) and rat intestinal trefoil factor (RITF) regions to drive luciferase expression.
(B) Schematic structure of the synthetic 116 bp operator, which consists of the two important components: LacO1 and LacO2.
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Luciferase activity was assayed 48 h after transfection
using a Dual-Luciferase Reporter Assay System kit (Pro-
mega, China). Cells were washed with PBS(−) and har-
vested in 200 μL of Passive Lysis Buffer (PLB, Promega,
China). After centrifugation at 12,000 rpm for 5 min at
4°C, the supernatant (100 μL) was transferred to a fresh
1.5 mL Eppendorf tube. Firefly and Renilla luciferase ac-
tivity was measured in a Synergy Mx Monochromator-
Based Multi-Mode Microplate Reader (BioTek, China).
Firefly luciferase activity was measured for 10 sec follow-
ing a 2 sec delay after the addition of the lysate (20 μL)
to 100 μL of LAR II (Promega, China), and Renilla luci-
ferase activity was measured for 10 sec following a 2 sec
delay after the addition of 100 μL Stop & GloW Reagent.
Data are presented as the relative activity of Firefly luci-
ferase to Renilla luciferase to normalize for transfection
efficiency.Determination of α-galactosidase mRNA levels
Total RNA was extracted using Trizol reagent according
to the manufacturer’s recommendations (Invitrogen,
China). First-strand cDNA synthesis was performed
using Oligo-(dT)18 (Invitrogen, China). The reaction mix
was subjected to RT-PCR to detect levels of α-Gal and
human β-actin mRNA. Human β-actin was used as an
internal control. The relative mRNA levels were deter-
mined and analyzed using the ABI Prism 7000 Sequence
Detection System (Applied Biosystems). Transfection
and assessment experiments were repeated three timesto analyze relative gene expression, and each sample was
tested in triplicate.
α-galactosidase activity assay
Enzyme activity was assayed in a reaction mixture con-
taining 0.1 mL of McIlvaine buffer (Phosphate and citric
acid ,100 mmol/L, pH = 4.8) and 0.5 mL of 20 mmol/L
p-nitrophenyl-α-D-galactopyranoside (pNPG) substrate
(den Herder et al., 1992) [24]. The reaction mixture was
pre-incubated at 37°C for 5 min before adding 0.2 mL of
enzyme solution (cell lysate). After 5 min, the reaction
was stopped by adding 1.5 mL of 0.1 mol/L Na2CO3 so-
lution. The released p-nitrophenol was determined spec-
trophotometrically at 405 nm using a calibration curve
prepared with p-nitrophenol under the same conditions.
One unit of α-galactosidase activity was defined as the
amount of enzyme liberating 1 μmol p-nitrophenol in
1 min under the assay conditions. The amount of pro-
tein was determined using a Bio-Rad dye-binding assay
(Bio-Rad Laboratories) and bovine serum albumin as
a standard.
Statistical analysis
All values are expressed as means ± SEM. The statistical
significance of the differences among groups was ana-
lyzed by one-way ANOVA. Multiple comparisons among
means were conducted using Tukey’s procedure when
significant difference was identified. Difference was
regarded as significant when P<0.05. All statistical ana-
lyses were performed using the SPSS 17.0 software
package.
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Construction of reporter plasmids containing intestinal
promoters: Comparative In Vitro study
Figure 2A shows that the HMUC2 promoter has the
highest activity among the intestine-specific promoters
tested, which was about 2 to 3 times higher than that of
the other three promoters (P < 0.05). RITF and HSI were

















































































Figure 2 Analysis of the activity and specificity of promoters/enhance
promoters was analyzed by transient transfection in SW480 cells. (B) Influen
(HMUC2) activity. (C) Luciferase activity of indicated plasmids in intestinal c
293T). Data are presented as the relative activity of Firefly luciferase to Reni
different wells. The means ± SEM of luciferase expression driven from the s
Different letters represent significant difference, P < 0.01.and surprisingly decreased (P < 0.05) the activity of
HMUC2 3-fold and 30-fold, respectively (Figure 2B).
Transfection of SW480, 293T, CHO, NIH-3T3, IPEC-1,
HeLa and HepG2 cells showed that the HMUC2 pro-
moter demonstrated better specificity in SW480 cells
than the other promoters tested. In contrast, some
intestine-specific promoters, such as HIFABP and HLY,
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lla luciferase in order to normalize transfection efficiency among
elected intestine-specific promoter/enhancers are represented.
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(Figure 2C).
Testing functional repressor binding to the lac operator
Regulation of reporter gene expression by the modified
lac operon system is shown in Figure 3. Co-transfection
of pNLacI and pHMLacO yielded luc activity about 6.5-
fold lower than with expression of pHMLacO alone (P <
0.05). When the inducers IPTG or α-lactose were added,
luc activity was increased (P < 0.05) 5-fold and 4.8-fold,
respectively, similar to that for transfection with
pHMLacO alone. These results (Figure 3A) indicate that
both IPTG and α-lactose could bind well to the repres-
sor and therefore eliminate (P < 0.05) its inhibitory
effect.
In addition, transient transfection with single
pHMLacO-GFP resulted in the generation of cells with



























Figure 3 Effects of IPTG and α-lactose on the transient expression of
transfection of SW480 cells with luciferase-containing and GFP-contai
expression of luciferase activity; lysates were derived from SW480 cells tran
before harvesting. Data are presented as relative activity of Firefly luciferase
among different wells. Different letters represent significant difference, P <
of GFP activity. a–e: FACS analysis of cells transfected with vectors shown (
IPTG, E: inducer α-lactose). The percentage of cells exhibiting strong fluores
exhibiting fluorescence.contrast, co-transfection of pHMLacO-GFP and pNLacI
gave rise to poor fluorescence. When the inducers
(IPTG and α-lactose) were added, the fluorescence in-
tensity was similar to cells transfected with pHMLacO-
GFP alone. FACS analysis showed that the percentage of
cells transfected with pHMLacO-GFP with GFP expres-
sion had a mean of 23.68%, while in SW480 cells trans-
fected with pHMLacO-GFP and pNLacI, it was below
11.68%. The numbers of cells exhibiting high degrees of
fluorescence increased to 19.80% and 20.03% when
IPTG and α-lactose were added, respectively.
Determination of α-galactosidase mRNA and protein
levels
Both mRNA levels and enzyme activity of α-galactosi-
dase were dramatically decreased (P < 0.05) by the
introduction of a repressor. When the inducers IPTG
and α-lactose were added, inhibition of the repressorb
a a
luciferase and green fluorescent protein (GFP) activity after
ning plasmids, respectively. (A) Effects of inducers on the transient
sfected with luciferase-containing plasmids and incubated for 48 h
to Renilla luciferase in order to normalize transfection efficiency
0.05. (B) Qualitative analysis of inducer effect on transient expression
A-E, A:pGL3-basic, B: pHMLacO, C: pNLacI and pHMLacO, D: inducer
cence (date marked area) was calculated as the number of cells
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mRNA levels and enzyme activity were increased
(P < 0.05) by 5-fold and 7-fold, respectively (Figure 4).
Discussion
Intestine-specific regulatory elements can achieve a
maximal expression of candidate genes in the gastro-
intestinal gut. Previous work has shown that some
intestine-specific promoters, such as HIFABP [9],
RIFABP [10], HMUC2 [11] and HLY [12], can efficiently
activate downstream gene expression in intestinal cells
or tissues. However, the promoter conferring the highest
activity has not yet been determined. Therefore, we first
compared the transcriptional characteristics of these
four promoters and found that the HMUC2 promoter
had the highest activity in SW480 cells, which was about
2 to 3 times higher than that of the other three promo-
ters. In addition, the HMUC2 promoter had low activity






































Figure 4 Effects of inducers on the transient expression of α-galactos
of α-Gal mRNA levels; β-actin was used to control transfection efficiency an
determinations with the SD indicated by error bars. Different letters represeresults are similar to previous work by Gum et al. [11],
who found that HMUC2 promoter activity was 4- to 6-
fold higher in Cla cells than in other cell lines (L cells,
AGS, HT-1080 and MGC80-3). Cla cells are a type of in-
testinal cell; however, HMUC2 promoter activity was not
investigated in other typical intestinal cell lines, such as
IPEC-1, SW480 or Coco-2. The activity of the HMUC2
promoter being highest in SW480 cells might relate to
transcription factors, such as the SP1 family, CDX2 and
GATA. Several lines of evidence demonstrate that
MUC2 promoter activity is greatly reduced by mutation
in the SP1 [25,26] and GATA-4 binding sites [27], while
CDX2 binding to the MUC2 gene cis element results in
a 5-fold enhancement in activity [28].
The other promoters we tested showed varying
degrees of non-specific activity. Rottman and Gordon
[29] reported that the RIFABP promoter has high activ-
ity in the Caco-2 cell line but still activates gene expres-





idase (α-Gal) mRNA and on α-Gal activity levels. (A) RT-PCR analysis
d cell recovery. (B) α-Gal activity assay. Values are the average of triple
nt significant difference, P < 0.01.
Zhai et al. Journal of Animal Science and Biotechnology 2012, 3:32 Page 8 of 10
http://www.jasbsci.com/content/3/1/32with our results. Paneth cells of the small intestine are a
rich source of lysozyme (encoded by HLY) [30], although
the HLY promoter has low activity in the small intestine
and can be detected in both HepG2 and U937 cell lines.
In addition, in vivo experiments also support the conclu-
sion that HLY promoter activity in the small intestine is
only about 5% of that in the lungs in transgenic mice
[12]. Hence, compared with IFABP and HLY promoters,
the HMUC2 promoter might be the most appropriate
regulatory element for intestine-specific gene expression.
To increase the strength of the intestine-specific pro-
moters, we produced a series of chimeric sequences by
combining the HMUC2 promoter with enhancers from
the HSI and RITF genes. The HSI enhancer contains
three nuclear protein-binding sites; SIF indicates the SI
(sucrase-isomaltase enhancer) footprint ,stands for west-
ern blot.. SIF1 is responsible for intestine-specific SI
transcription and can act as an enhancer for the SI pro-
moter [31]. SIF2 and SIF3 bind hepatocyte nuclear factor
(HNF-1α and HNF-1β) [32] The RITF enhancer, con-
taining a 9 base pair (CCCCTCCCC) element between
−154 and −118 in the RITF promoter, is a cis-active
element bound by a distinct nuclear transcription factor
and is capable of increasing promoter activity [14]. We
fused the RITF and HSI enhancers with the HMUC2
promoter, to generate a promoter predicted to have
strong intestine-specific activity. However, the opposite
results were observed; HMUC2 promoter activity was
decreased 3-fold and 30-fold by the RITF and HSI
enhancers, respectively. This result may be explained by
promoter specificity and the location and orientation of
a non-classical enhancer. Troelsen et al. [33] found that
the intestinal lactase phlorizin hydrolase (LPH) enhancer
is only active in front of intestine-specific promoters,
such as LPH and SI promoters, but not the SV40 pro-
moter. It is worth noting that the LPH enhancer could
inhibit SI promoter activity irrespective of location and
orientation. Thus, the effects of location and orientation
of the HSI and RITF enhancers on the activity of
intestine-specific promoters still needs further study.
Inducible systems that incorporate cell-specific promo-
ters enable a target gene to be switched on and off re-
peatedly when needed without affecting the expression of
non-targeted genes. In recent years, binary systems based
on the interaction of two components, such as the lac
operon system [15], the tetR-based system [16], the
GAL4-based system [17] and the Cre/loxP recombin-
ation system [18] have been used to turn gene expression
on and off. The VP16-activating domain in the TetR-
based system and the GAL4-based system has been
found to be toxic to cells [16]. The Cre/loxP system had
been widely used in gene activation with non-reversible
effects, while the lac operon system has successfully
used mammalian regulatory elements to control geneexpression in mammalian cells and transgenic mice for
some time [15,19]. Most importantly, α-galactosidase
gene expression based on the lac operon system could
be increased along with the production of α-lactose be-
cause α-lactose is both the inducer of the lac operon
system and the substrate of α-galactosidase. Therefore,
we constructed a modified lac operon system consisting
of two important components: the 116-bp operator and
the repressor with a nuclear localization signal (NLS)
added before the termination codon (TAG). In the lac
operon system, luc activity and the percentage of cells
with GFP expression were decreased 6.5-fold and 2-fold,
and the α-galactosidase mRNA level and α-galactosidase
activity were reduced 6-fold and 8-fold, respectively, due
to inhibition by the repressor, which could be relieved
when IPTG or α-lactose was added. These results were
similar to those of previous studies [34].
We also found that the lac operon had a low-level
leakiness; the target gene was still expressed at a low level
when the repressor bound to the lac operator. This
phenomenon was also investigated by Wyborski and
DuCoeur, although they had successfully used the lac op-
eron to regulate gene expression in vivo [20]. The LacO
inserted at both −10 and −35 led to promoter activity
being decreased 45-fold in the presence of a repressor
[19]. In addition, the specificity of the repressor-operator
interaction can be further increased by introducing a
small degree of asymmetry in the operator; the symmetry
in the operator alters the translational efficiency, but it
cannot affect transcription [35]. We observed that α-
galactosidase mRNA and protein levels have a similar
trend, shown in Figure 4, which suggested that the loca-
tion rather than the symmetry of the operator in the
HMUC2 promoter should be changed to reduce the low-
level leakiness. Re-encoding or mutating some amino
acids in the lacI sequence can significantly improve sup-
pression capability, as has been successfully shown by
Mueller-Hartmann and Mueller-Hill [36]. Thus, the
problem of low-level leakiness can be overcome in future
work by altering the location of LacO and by introducing
appropriate mutations into the LacI sequence.
α -galactosidase has drawn much attention due to its
wide use in Fabry disease therapy and in feed additives
to increase nutrition utilization efficiency and animal
growth [4-6].
Although human α-galactosidase has been successfully
applied in transgenic mice [1,7], it is uncertain whether
bacterial α-galactosidase can be expressed in mammalian
cells and transgenic animals. Some evidence reports that
bacterial genes introduced into the mammalian genome
are difficult to express due to methylation [37]. However,
bacterial xylanase has been successfully used in trans-
genic mice, and activity of the enzyme can be detected
up to 4.2 U/mg [38]. Our present results indicate that
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expressed in mammalian cells and that α-galactosidase
activity could be measured at about 24 U/mg. Several
in vivo studies have shown that α-galactosidase supple-
mentation with 0.08 U/kg feed in growing pig diets con-
taining soybean meal and with 2.3 U/kg feed in piglet
diets could significantly improve Gain:Feed by 6% and
increase the digestibility of carbohydrates and protein in
the small and large intestine [39,40]. Therefore, our in-
ducible and highly-efficient α-galactosidase expression
system might provide the basis for further transgenic
pig production. The intestine-specific inducible system
could also be beneficial for studying the function and
effect of other exogenous genes in transgenic animals.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ZYF participated in the design of the study, carried out the experiments,
statistical analysis and wrote the first draft of the manuscript. SG participated
in the design of the study and the statistical analysis, and oversaw
manuscript preparation. ZXT and ZZQ participated in the cell experiments
and plasmid construction. WSB, WLN, ZYL and JQY participated in study
design and coordination. LXJ participated in writing the final versions of the
manuscript. All authors have read and approved the final manuscript.
Acknowledgements
We would like to thank Prof. Yao (Feed Research Institute Chinese Academy
of Agricultural Sciences, China) for providing the pPIC9-Agil vector. This work
was supported by the National Key Project (2009CB941601, 2008ZX08006-
004 and 2009ZX0890-024B) and the Joint Funds of the National Natural
Science Foundation of China (u0731004).
Received: 28 April 2012 Accepted: 15 October 2012
Published: 30 October 2012
References
1. Ohashi T, Iizuka S, Ida H, Eto Y: Reduced alpha-Gal A enzyme activity in
Fabry fibroblast cells and Fabry mice tissues induced by serum from
antibody positive patients with Fabry disease. Mol Genet Metab 2008,
94:313–318.
2. Lenny LL, Hurst R, Goldstein J, Galbraith RA: Transfusions to group O
subjects of 2 units of red cells enzymatically converted from group B to
group O. Transfusion 1994, 34:209–214.
3. Leske KL, Coon CN: Hydrogen gas production of broiler chicks in
response to soybean meal and alpha-galactoside free, ethanol-extracted
soybean meal. Poultry Sci 1999, 78:1313–1316.
4. Igbasan FA, Guenter W, Slominski BA: The effect of pectinase and alpha-
galactosidase supplementation on the nutritive value of peas for broiler
chickens. Can J Anim Sci 1997, 77:537–539.
5. Waldroup PW, Keen CA, Yan F, Zhang K: The effect of levels of alpha-
galactosidase enzyme on performance of broilers fed diets based on
corn and soybean meal. J Appl Poultry Res 2006, 15:48–57.
6. Ghazi S, Rooke JA, Galbraith H: Improvement of the nutritive value of
soybean meal by protease and alpha-galactosidase treatment in broiler
cockerels and broiler chicks. Brit Poultry Sci 2003, 44:410–418.
7. Ishii S, Yoshioka H, Mannen K, Kulkarni AB, Fan JQ: Transgenic mouse
expressing human mutant α-galactosidase A in an endogenous enzyme
deficient background: a biochemical animal model for studying active-
site specific chaperone therapy for Fabry disease. Bba-Mol Basis Dis 2004,
1690:250–257.
8. Horn C, Wimmer EA: A transgene-based, embryo-specific lethality system
for insect pest management. Nat Biotechnol 2003, 21:64–70.
9. Klapper M, Boehme M, Nitz I, Doering F: The human intestinal fatty acid
binding protein (hFABP2) gene is regulated by HNF-4 alpha. Biochem
Bioph Res Co 2007, 356:147–152.10. Sweetser DA, Hauft SM, Hoppe PC, Birkenmeier EH, Gordon JI: Transgenic
mice containing intestinal fatty acid-binding protein-human growth
hormone fusion genes exhibit correct regional and cell-specific
expression of the reporter gene in their small intestine. P Natl Acad Sci
USA 1988, 85:9611–9615.
11. Gum JR Jr, Hicks JW, Toribara NW, Siddiki B, Kim YS: Molecular Cloning of
Human Intestinal Mucin (MUC2) cDNA: Identification of the amino
terminus and overall sequence similarity to prepro-Von Willebrand
factor. J Biol Chem 1994, 269:2440–2446.
12. Clarke S, Greaves DR, Chung L-P, Tree P, Gordon S: The human lysozyme
promoter directs reporter gene expression to activated myelomonocytic
cells in transgenic mice. P Natl Acad Sci USA 1996, 93:1434–1438.
13. Wu GD, Wang W, Traber PG: Isolation and characterization of the human
sucrase-isomaltase gene and demonstration of intestine-specific
transcriptional elements. J Biol Chem 1992, 267:7863–7870.
14. Ogata H, Inoue N, Podolsky DK: Identification of a goblet cell-specific
enhancer element in the rat intestinal trefoil factor gene promoter
bound by a goblet cell nuclear protein. J Biol Chem 1998, 273:3060–3067.
15. Cronin CA, Gluba W, Scrable H: The lac operator-repressor system is
functional in the mouse. Gene Dev 2001, 15:1506–1517.
16. Baron U, Gossen M, Bujard H: Tetracycline-controlled transcription in
eukaryotes: novel transactivators with graded transactivation potential.
Nucleic Acids Res 1997, 25:2723–2729.
17. Ornitz DM, Moreadith RW, Leder P: Binary system for regulating transgene
expression in mice: targeting int-2 gene expression with yeast GAL4/
UAS control elements. P Natl Acad SCI 1991, 88:698.
18. Gu H, Zou YR, Rajewsky K: Independent control of immunoglobulin
switch recombination at individual switch regions evidenced through
Cre-loxP-mediated gene targeting. Cell 1993, 73:1155.
19. Hu MC, Davidson N: The inducible lac operator-repressor system is
functional in mammalian cells. Cell 1987, 48:555–566.
20. Wyborski DL, DuCoeur LC, Short JM: Parameters affecting the use of the
lac repressor system in eukaryotic cells and transgenic animals. Environ
Mol Mutagen 1996, 28:447–458.
21. Scrable H, Stambrook PJ: Activation of the lac repressor in the transgenic
mouse. Genet 1997, 147:297–304.
22. Oehler S, Eismann ER, Kramer H, Muller-Hill B: The three operators of the
lac operon cooperate in repression. EMBO J 1990, 9:973–979.
23. Oehler S, Amouyal M, Kolkhof P, Wilcken-Bergmann BV, Mueller-Hill B:
Quality and position of the three lac operators of E. coli define efficiency
of repression. EMBO J 1994, 13:3348–3355.
24. den Herder IF, Rosell AM, van Zuilen CM, Punt PJ, van den Hondel CA:
Cloning and expression of a member of the Aspergillus niger gene
family encoding alpha-galactosidase. Mol Gen Genet 1992, 233:404–410.
25. Nogami H, Ohmori H, Li JD, Gallup M, Gum J, Kim Y, Basbaum C: Sp1
protein contributes to airway-specific rat< i> MUC 2</i> mucin gene
transcription. Gene 1997, 198:191–201.
26. Aslam F, Palumbo L, Augenlicht LH, Velcich A: The Sp family of
transcription factors in the regulation of the human and mouse MUC2
gene promoters. Cancer Res 2001, 61:570.
27. van der Sluis M, Melis MHM, Jonckheere N, Ducourouble MP, Büller HA,
Renes I, Einerhand AWC, Van Seuningen I: The murine Muc2 mucin gene
is transcriptionally regulated by the zinc-finger GATA-4 transcription
factor in intestinal cells. Biochem Bioph Res Co 2004, 325:952–960.
28. Yamamoto H, Bai YQ, Yuasa Y: Homeodomain protein CDX2 regulates
goblet-specific MUC2 gene expression. Biochem Bioph Res Co 2003,
300:813–818.
29. Rottman JN, Gordon JI: Comparison of the patterns of expression of rat
intestinal fatty acid binding protein/human growth hormone fusion
genes in cultured intestinal epithelial cell lines and in the gut epithelium
of transgenic mice. J Biol Chem 1993, 268:11994–12002.
30. Keshav S, Chung P, Milon G, Gordon S: Lysozyme is an inducible marker of
macrophage activation in murine tissues as demonstrated by in situ
hybridization. J Exp Med 1991, 174:1049.
31. Rodolosse A, Chantret I, Lacasa M, Chevalier G, Zweibaum A, Swallow D,
Rousset M: A limited upstream region of the human sucrase-isomaltase
gene confers glucose-regulated expression on a heterologous gene.
Biochem J 1996, 315:301–306.
32. Rodolosse A, Carriere V, Rousset M, Lacasa M: Two HNF-1 binding sites
govern the glucose repression of the human sucrase-isomaltase
promoter. Biochem J 1998, 336:115–123.
Zhai et al. Journal of Animal Science and Biotechnology 2012, 3:32 Page 10 of 10
http://www.jasbsci.com/content/3/1/3233. Troelsen JT, Mitchelmore C, Olsen J: An enhancer activates the pig lactase
phlorizin hydrolase promoter in intestinal cells. Gene 2003, 305:101–111.
34. Daber R, Lewis M: Towards evolving a better repressor. Protein Eng Des Sel
2009, 22:673–683.
35. Daber R, Lewis M: A Novel Molecular Switch. J Mol Biol 2009, 391:661–670.
36. Müller-Hartmann H, Müller-Hill B: The side-chain of the amino acid residue
in position 110 of the Lac repressor influences its allosteric equilibrium. J
Mol Biol 1996, 257:473–478.
37. Nilsson E, Lendahl U: Transient expression of a human β-‐actin promoter/
lacZ gene introduced into mouse embryos correlates with a low degree
of methylation. Mol Reprod Dev 1993, 34:149–157.
38. Fontes CMGA, Ali S, Gilbert HJ, Hazlewood GP, Hirst BH, Hall J: Bacterial
xylanase expression in mammalian cells and transgenic mice.
J Biotechnol 1999, 72:95–101.
39. Gdala J, Johansen HN, Bach Knudsen KE, Knap IH, Wagner P, Jørgensen O:
The digestibility of carbohydrates, protein and fat in the small and large
intestine of piglets fed non-supplemented and enzyme supplemented
diets. Anim Feed Sci Tech 1997, 65:15–33.
40. Baucells F, Pérez J, Morales J, Gasa J: Effect of alpha-galactosidase
supplementation of cereal-soya-bean-pea diets on the productive
performances, digestibility and lower gut fermentation in growing and
finishing pigs. J Anim Sci 2000, 71:157–164.
doi:10.1186/2049-1891-3-32
Cite this article as: Zhai et al.: Identification of an intestine-specific
promoter and inducible expression of bacterial α-galactosidase in
mammalian cells by a lac operon system. Journal of Animal Science and
Biotechnology 2012 3:32.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
